Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer
Clinical trial NCT04397926 · UNKNOWN
Trial details
- NCT number
- NCT04397926
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-30
- Primary completion
- 2022-05-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.